Showing results (161-170 of 183) with videos related to
Sort By:
Pageof 19
The New England Journal of Medicine|December 31, 1992
Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study GroupL B Seeff, Z Buskell-Bales, E C Wright, et al.Hepatology (Baltimore, Md.)|September 25, 1999
Extended lamivudine retreatment for chronic hepatitis B: maintenance of viral suppression after discontinuation of therapyJ L Dienstag, E R Schiff, M Mitchell, et al.The Journal of Clinical Investigation|February 1, 1994
Hepatitis B virus precore mutation and fulminant hepatitis in the United States. A polymerase chain reaction-based assay for the detection of specific mutationT J Liang, K Hasegawa, S J Munoz, et al.Journal of Hepatology|December 12, 2001
Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis BY O Kweon, Z D Goodman, J L Dienstag, et al.Clinical Therapeutics|March 1, 1994
Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact ProfileG L Davis, L A Balart, E R Schiff, et al.Journal of Hepatology|January 1, 1990
Treatment of chronic hepatitis C with recombinant alpha-interferon. A multicentre randomized, controlled trial. The Hepatitis Interventional Therapy GroupG L Davis, L A Balart, E R Schiff, et al.The New England Journal of Medicine|November 30, 1989
Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trialG L Davis, L A Balart, E R Schiff, et al.Science (New York, N.Y.)|April 21, 1989
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitisG Kuo, Q L Choo, H J Alter, et al.JAMA|August 23, 1985
Absence of antibodies to HTLV-III in health workers after hepatitis B vaccinationJ L Dienstag, B G Werner, M F McLane, et al.Gastroenterology|February 1, 1993
Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy GroupJ H Lefkowitch, E R Schiff, G L Davis, et al.Pageof 19